TRPH-222 Shows Significant Anti-tumor Activity in Lymphoma Preclinical Models
News
An investigational antibody-drug conjugate, TRPH-222, effectively reduced tumor burden in mice with diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL), and is well-tolerated in non-human primates, a new ... Read more